Abstract
It has been known for over a century that the cardiac glycosides affect the autonomic nervous system and that both the sympathetic and parasympathetic components can be involved. This review will look mainly at the evidence for the autonomic effects of peripherally administered cardiac glycosides as well as postulated mechanisms and will not consider in great detail work concerned with the effects of the cardiac glycosides on the central nervous system.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abiko, Y., Mukahira, K., Tanabe, T.: On the role of vagi and sinus nerves in the reflexogenic inhibition of sympathetic discharges induced by strospeside in cats. Jpn. J. Pharmac. 15, 143–148 (1965)
Anagnoste, B., Goldstein, M: The effects of ouabain on cathecolamine biosynthesis in different areas of rats’ brains. Pharmacologist 9, 210 (1967)
Angelucci, L., Lorentz, G., Baldieri, M.: The relation between noradrenaline content of rabbit heart muscle and the amount of k-strophanthin needed to produce arrhythmias. J. Pharm. Pharmacol. 18, 775–782 (1966)
Attree, T., Sawyer, P., Turnbull, M.J.: Interaction between digoxin and tricyclic anti-depressants in the rat. Eur. J. Pharmacol. 19, 294–296 (1972)
Basu-Ray, B.N., Dutta, S.N., Pradhan, S.N.: Effects of microinjections of ouabain into certain medullary areas in cats. J. Pharmacol. Exp. Ther. 181 (2) 357–361 (1972)
Bazzi, U., Nicolisi, G.: Modificazioni indotte dalla somministrazione a dosi massive di sostanze a nucleo sterolico sulla eliminazione di steroidi ormonici dell’ urina (11-ossicorticosteroidi, 17-chetosteroidi). II. Azione della digitale. Boll. Soc. Ital. Biol. Sper. 27, 1307–1308 (1951)
Bloch, K.: Zur Pathogenese der Mamma-Hypertrophie bei der Digitalis-Applikation. Z. Kreislaufforsch. 50, 591–595 (1961)
Borison, H.L., Brizzee, K.R.: Morphology of emetic chemoreceptor trigger zone in the cat medulla oblongata. Proc. Soc. Exp. Biol. Med. 77, 38–42 (1951)
Borison, H.L., Wang, S.C.: The vomiting center: Its destruction by radon implantation in dog medulla oblongata. Am. J. Physiol. 166, 712–717 (1951)
Borison, H.L., Wang, S.C.: Physiology and pharmacology of vomitting. Pharmacol. Rev. 5, 193–230 (1953)
Borsch-Galetke, E., Dransfeld, H., Greeff, K.: Specific activity and sensitivity to strophanthin of the Na+ +K+-activated ATP-ase in rats and guinea-pigs with hypoadrenalism. Naunyn Schmiedebergs Arch. Pharmacol. 274, 74–80 (1972)
Boyajy, L.D., Nash, C.B.: Influence of reserpine on arrhythmias, inotropic effects, and myocardial potassium balance induced by digitalis materials. J. Pharmacol. Exp. Ther. 148/ 2, 193–201 (1965)
Boyd, E.M., Brown, M.D., Cassell, W.A.: Delayed vomiting induced in dogs by intramuscular digoxin. J. Pharm. Pharmacol. 11, 742–746 (1959)
Busse, W. von, Loennecken, S.J.: Pharmakologische Beeinflußbarkeit reflektorisch-toxischer Digitaliswirkungen (Bradykardie and Erbrechen) über die Herznerven. Naunyn Schmiedebergs Arch. Pharmacol. 220, 232–244 (1953)
Busse, W. von, Göing, H., Lendle, L.: Einfluß des erhöhten Vagustonus auf die Strophanthintoxizität am Herzen. Z. Kreislaufforsch. 44, 604–608 (1955)
Calove, W.L., Whyte, H.M.: Oedema and mammary hypertrophy: a toxic effect of digitalis leaf. Med. J. Aust. 1, 556–557 (1954)
Carpenter, C.C.J., Davis, J.O., Wallace, C.R., Hamilton, W.F.: Acute effects of cardiac glycosides on aldosterone secretion in dogs with hyperaldosteronism secondary to chronic right hart failure. Circ. Res. 10, 178–187 (1962)
Chai, C.Y., Wang, H.H., Hoffmann, B.F., Wang, S.C.: Mechanisms of bradycardia induced by digitalis substances. Am. J. Physiol. 212, 26–34 (1967)
Croxson, M.S., Ibbertson, H.K.: Serum digoxin in patients with thyroid disease. Br. Med. J. 3, 566–568 (1975)
Cushman, P.: Inhibition of abdosterone secretion by ouabain in dog adrenal cortical tissue. Endocrinology 84, 808–813 (1969)
Dagget, W.M., Weisfeldt, M.L.: Influence of the sympathetic nervous system on the response of the normal heart to digitalis. Am. J. Cardiol. 16, 394–405 (1965)
Dal-Ri, H., Schmidt, G.: Central and peripheral alteration of respiration by toxic cardiac glycosides in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 239, 158–169 (1960)
Davis, J.O.: Mechanism of salt and water retention in congestive heart failure. Am. J. Med. 29, 486 (1960)
Deane, H.W., Gardener, L.I.: Notes and comments: Ouabain and the adrenal cortex. Endocrinology 48, 237–238 (1951)
Dengler, J.H., Michaelson, I.A., Spiegel, H.E., Titus, E.: The uptake of labelled norepinephrine by isolated brain and other tissues of the cat. Intern. J. Neuropharmacol. 1, 23–28 (1962)
Doggett, N.S., Case, G.: Some observation on the interaction between cardiac glycosides and reserpine in the heart and central nervous system. Toxicol. Appl. Pharmacol. 33, 87–93 (1975)
Doggett, N.S., Spencer, P.S.J.: Pharmacological properties of centrally administered ouabain and their modification by other drugs. Br. J. Pharmacol. 42, 242–253 (1971)
Dresbach, M.: Additional experiments relative to the origin of glycoside emesis using cats and dogs. Am. J. Physiol. 126, 480 (1939)
Dresbach, M.: Further experiments in attempt to locate site of emetic action of digitalis glycosides. J. Pharmacol. Exp. Ther. 91, 307–316 (1947)
Dresbach, M., Waddell, K.C.: Question of reflex vomiting from heart induced by digitalis bodies. J. Lab. Clin. Med. 14, 625–630 (1929)
Dutta, S., Marks, B.H., Schoener, E.P.: Accumulation of radioactive cardiac glycosides by various brain regions in relation to the dysrhythmogenic effect. Br. J. Pharmacol. 59, 101–106 (1977)
Eckstein, J.W., Abboud, F.M., Pereda, S.A.: Hemodynamic responses to administration of acetyl strophanthidin before and after ganglionic blockade in normal dogs and in dogs treated with reserpine. J. Lab. Clin. Med. 58, 814–815 (1961)
Eggleston, C.: The antagonism between atropine and certain central emetics. J. Pharmacol. Exp. Ther. 9, 11–25 (1916)
Eikenburg, D.C., Stickney, J.L.: Inhibition of sympathetic neuronal transport and ouabaininduced cardiac arrhythmias. Res. Commun. Chem. Pathol. Pharmacol. 18 (4), 587–599 (1977)
Farges, J.P., Ollanger, M., Lievre, M., Faucon, G.: Influence of cardiac cholinergie impregnation on the effects of ouabain on atrial and ventricular myocardium. J. Pharmacol. (Paris) 9 (1), 65–75 (1978)
Fawaz, G.: Effect of reserpine and pronethalol on the therapeutic and toxic actions of digitalis in the dog heart-lung preparation. Br. J. Chemother. 29, 302–308 (1967)
Förster, W., Kalsow, H.: Über den unterschiedlichen Einfluß von Dichlorisoproterenol auf den positiv inotropen Effekt verschiedener Digitaliskörper am isolierten Vorhof-Aurikelpräparat des Meerschweinchen. Acta. Biol. Med. Ger. 15, 71–78 (1965)
Förster, W., Sziegoleit, W., Guhlke, I.: Vergleichende Untersuchung einiger extra-cardialer Effekte von herzwirksamen Glykosiden. Arch. Int. Pharmacodyn. 155 (1), 165–182 (1965)
Gaffney, T.E., Kahn, J.B., van Maanen, E.F.: A mechanism of the vagal effect of cardiac glycosides. J. Pharmacol. Exp. Ther. 122, 423–429 (1958)
Gaitondé, B.B., Joglekar, S.N.: Role of catecholamines in the central mechanism of emetic response induced by peruvoside and ouabain in cats. Br. J. Pharmacol. 54 (2), 157–162 (1975)
Gaitondé, B.B., McCarthy, L.E., Borison, H.L.: Central emetic action and toxic effects of digitalis in cats. J. Pharmacol. Exp. Ther. 147 (3), 409–415 (1965)
Gardner, L.I., Berman, H., Deane, H.W.: Metabolic ompetition between descoxycorticosterone acetate and strophanthin-g in the rat. Endocrinology 55, 417–427 (1954)
Gillis, R.A.: Cardiac sympathetic nerve activity: Changes induced by ouabain and propranolol. Science 166, 508–510 (1969)
Gillis, R.A., Raines, A., Sohn, Y.J., Levitt, B., Standaert, F.G.: Neuroexcitatory effects of digitalis and their role in the development of cardiac arrhythmias. J. Pharmacol. Exp. Ther. 183 (1), 154–158 (1972)
Gillis, R.A., Helke, C.J., Kellar, K.J., Quest, J.A.: Autonomic nervous system actions of cardiac glycosides. Biochem. Pharmacol. 27, 849–856 (1978)
Göthert, M.: Der Einfluß von Digitoxin auf die Noradrenalinkonzentration im Myocard. Arzneim. Forsch. 21, 1333–1334 (1971)
Gold, H., Kwit, N.T., Otto, H., Fox, T.: On vagal and extravagal factors in cardiac slowing by digitalis in patients with auricular fibrillation. J. Clin. Invest. 18, 429–437 (1939)
Gold, H., Greiner, T., Cattell, M., Modell, W., Gluck, J., Marsh, R., Mathes, S., Hudson, D., Robertson, D., Warshaw, L., Otto, H., Kwit, N., Kramer, M.: Difference in the relation of cardiac to emetic actions in oral and parenteral digitalization. Am. J. Med. 13, 124–144 (1952)
Goldstein, M., Ohi, Y., Backstrom, T.: The effect of ouabain on catecholamine biosynthesis in rat brain cortex slices. J. Pharmacol. Exp. Ther. 174, 77–82 (1970)
Gomoll, A.W.: Influence of ouabain on the formation of corticosterone in the rat adrenal gland. J. Pharmacol. Exp. Ther. 156 (2), 300–309 (1967)
Gomoll, A.W., Sherrod, T.R.: Influence of acetylstrophanthin on aldosterone secretion in the intact anesthetized dog. Arch. Int. Pharmacodyn. 150 (3), 469–482 (1964)
Goodman, D.J., Rossen, R.M., Cannom, D.S., Rider, A.K., Harrison, D.C.: Effect of digoxin and atrioventricular conduction: Studies in patients with and without cardiac autonomic innervation. Circulation 51 (2), 251–256 (1975)
Greeff, K.: Mineralstoffwechselwirkung und Toxicität des Strophanthins bei nebennierenlosen Ratten. Arch. Exp. Pathol. Pharmakol. 231, 391–400 (1957)
Greeff, K., Kasperat, H.: Vergleich der neurotoxischen Wirkung von Digitalisglykosiden und Geninen bei intra-cerebraler und intravenöser Injektion an Mäusen, Ratten und Meerschweinchen. Naunyn Schmiedebergs Arch. Pharmacol. 242, 76–89 (1961)
Greeff, K., Westermann, E.: Untersuchung über die muskellähmende Wirkung des Strophanthins. Naunyn Schmiedebergs Arch. Pharmacol. 226, 103–113 (1955)
Greenspan, K., Lord, T.J.: Digitalis and vagal stimulation during atrial fibrillation: effects on atrioventricular conduction and ventricular arrhythmias. Cardiovasc. Res. 7, 241–246 (1973)
Guozdjak, J., Niederland, T.R., Honanova, J., Kovacikova, B.: Dynamic investigation of the biochemical changes in the adrenal glands of rats after the administration of digitoxin. Arch. Int. Pharmacodyn. 81 (4), 390–396 (1961)
Halonen, P.I., Kuusisto, A.N., Koskelo, P.: On the effect of strophanthin on thyroid activity. Cardiologia 21, 727–734 (1952)
Harvey, S.C.: The effects of ouabain and phenytoin on myocardial noradrenaline. Arch. Int. Pharmacodyn. 213, 222–234 (1975)
Hatcher, R.A., Eggleston, C.: The emetic action of digitalis bodies. J. Pharmacol. Exp. Ther. 4, 113–134 (1912)
Hatcher, R.A., Weiss, S.: Studies on vomiting. J. Pharmacol. Exp. Ther. 22, 139–193 (1923)
Hatcher, R.A., Weiss, S.: Seat of emetic action of digitalis bodies. J. Pharmacol. Exp. Ther. 32, 37–53 (1927)
Heim, F., Bänder, A.: Der Einfluß von Strophanthin auf die Vagus-Erregbarkeit des normalen und geschädigten Warmblüterherzens. Arch. Exp. Pathol. Pharmakol. 212, 456–462 (1951)
Helke, C.J., Souza, J.D., Hamilton, B.L., Morgenroth, V.H., Gillis, R.A.: Evidence for a role of central serotonergic neurones in digitalis-induced cardiac arrhythmias. Nature 263, 246–248 (1976)
Hoffmann, G., Lendle, L.: Kritisches zur Digitalisauswertung am Meerschweinchen. Naunyn Schmiedebergs Arch. Pharmacol. 212, 376–385 (1951)
Hoffmann, G., Lendle, L.: Nachweis extrakardialer Digitaliswirkungen an der Ratte. Arch. Exp. Pathol. Pharmakol. 217, 184–193 (1953)
Hohensee, T., Lendle, L.: Über die Frage einer Vaguswirkung von Digitalisglykosiden. Naunyn Schmiedebergs Arch. Pharmacol. 207, 388–408 (1949)
Joubert, P.H.: Digitalis in clinical practice. S. Afr. Med. J. 50, 146–152 (1976)
Joubert, P.H., van der Meer, L.: Digitalis preparations show pharmacodynamic differences with important clinical implications. In: IUPHAR 7th International Congress of Pharmacology, Paris 16–21 July, 1978, Abstracts. Boissien, J.R., Ledrat, P. (eds.), p. 917. Oxford: Pergamon 1978
Kelliher, G.J., Roberts, J.: Effect of 6-hydroxydopamine on ouabain induced arrhythmia. Clin. Res. 20, 857 (1972)
Kien, G.A., Gomoll, A.W., Sherrod, T.R.: Action of digoxin and insulin on transport of glucose through myocardial cell membrane. Proc. Soc. Exp. Biol. Med. 103, 682–685 (1960)
Kirpekar, S.M., Prat, J.C., Yamamoto, H.: Effects of metabolic inhibitors on norepinephrine release from the perfused spleen of the cat. J. Pharmacol. Exp. Ther. 172, 342–350 (1970)
Kitzes-Cohen, R., Neri, A., Schehter, A., Rosenfeld, J.: Estrogen like activity of digoxin, its correlation to vaginal cytology, to digoxin serum levels and Kupperman index. 7th International Congress of Pharmacology, Paris, 16–21 Juli 1978, Abstracts. Boissier, J.R., Lechat, P. (eds.), p. 675. Oxford: Permagon 1978
Koch-Weser, J.: Beta-receptor blockade and myocardial effects of cardiac glycosides. Circ. Res. 28, 109–118 (1971)
Korth, C., Marx, H., Weinberg, S.: Über die Wirkung des Strophanthins auf das Zentralnervensystem. Naunyn Schmiedebergs Arch. Pharmacol. 185, 42–56 (1937)
Kuusisto, A.N., Koskelo, P., Halonen, P.I.: Über die Wirkung von Digitalis und MethylThiourazil auf die Schilddrüse bei gleichzeitiger Zufuhr. Ann. Med. Exp. Fenn. 31, 74–81 (1953)
Kypson, J., Triner, L., Nahas, G.G.: The effects of cardiac glycosides and their interaction with catecholamines on glycolysis and glycogenolysis in skeletal muscle. J. Pharmacol. Exp. Ther. 1641, 22–30 (1968)
Lasché, E.M., Perloff, W.H., Durant, Th. M.: Some aspects of adrenocortical function in cardiac decompensation. Am. J. M.d. Sci. 222, 459–467 (1951)
Lefer, A.M., Sayers, G.: Antagonism of the inotropic action of ouabain by aldosterone. Am. J. Physiol. 208, 649–654 (1965)
Leitz, F.H., Stefano, F.J.E.: Effect of ouabain and desimipramine on the uptake and storage of norepinephrine and metaraminol. Eur. J. Pharmacol. 11, 278–285 (1970)
Lendle, L., Mercker, H.: Extrakardiale Digitaliswirkungen. Ergeb. Physiol. 51, 200–298 (1961)
Lendle, L., Mercker, H., Rohr, H.: Über die Herzvaguswirkung unter dem Einfluß von Digitalglykosiden. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmak. 219, 352–361 (1953)
Lendle, L., Oldenburg, D.: Prüfung extrakardialer Wirkung an der Digitalis-unterempfindlichen Ratte. Arch. Exp. Pathol. Pharmakol. 211, 243–263 (1950)
Lendle, L., Wienke, H.: Zur Frage der Sensibilisierung von Vaguswirkungen auf die Herzfrequenz durch Digitalis. Arch. Exp. Pathol. Pharmakol. 213, 373–386 (1951)
Levitt, B., Roberts, J.: Effect of quinidine and pronethalol on acetylstrophanthidin-induced ventricular arrhythmia in cats treated with reserpine. Circ. Res. 19, 622–631 (1966)
Levy, J.V., Richards, V.: Inotropic effects of ouabain on rabbit left atria in presence of betaadrenergic blocking drugs. Proc. Soc. Exp. Biol. Med. 119, 278–281 (1965a)
Levy, J.V., Richards, V.: The influence of reserpine pretreatment on the contractile and metabolic effects produced by ouabain on isolated rabbit left atria. J. Pharmacol. Exp. Ther. 1472, 205–211 (1965b)
Le Winn, E.B.: Gynaecomasta during digitalis therapy. N. Engl. J. Med. 248, 316–319 (1953)
Le Winter, M.M., Crawford, M.H., O’Rourke, R.A., Kaliner, J.S.: The effects of oral propranolol, digoxin, and combination therapy on the resting and exercise electrocardiogram. Am. Heart J. 932, 202–209 (1977)
Massaro, G.D., Finnerty, F.A., Ryan, M.: The effect of reserpine and digitalis on the heart rate during nor-adrenaline infusion. Am. Heart J. 59, 401–403 (1960)
Matheny, J.L., Ahlquist, R.P.: Effect of digitalis on carotid sinus reflex in the rabbit. Fed. Exp. Proc. 32, 717 (1973)
McLain, P.L.: Effects of cardiac glycosides on spontaneous efferent activity in vagus and sympathetic nerves of cats. Int. J. Neuropharm. 8, 379–387 (1969)
McLain, P.L., Kruse, T.K., Redick, T.F.: The effect of atropine on digitoxin bradycardia in cats. J. Pharmacol. Exp. Ther. 126, 76–81 (1959)
Melville, K.I., Shister, H.E.: General systemic effect and electrocardiographic changes following injections of digitalis glycosides into the lateral ventricle of the brain. Am. Heart J. 53, 425–438 (1957)
Metzler, A. von: Über die Wirkung von Strophanthin, Percorten, akuter und chronischer Ammoniakvergiftung auf Herz und Nebennieren von ruhenden und arbeitenden Meerschweinchen. Arch. Kreislaufforsch. 17, 56–71 (1951)
Metzler, A. von, Greeff, K.: Über den Mechanismus der durch K-Strophanthin verursachten Nebennieren-und Herzhypertrophie. Arch. Exp. Pathol. Pharmakol. 222, 352–359 (1954)
Metzler, A. von, Hergott, J.: Über den Einfluß des Percortens auf toxische Strophanthindosen am Froschherzen in situ. Klin. Wochenschr. 2956, 91–92 (1951)
Morrow, D.H., Gaffney, T.E., Braunwald, E.: Studies on digitalis. VII. Influence of hyper-and hypothyroidism on the myocardial response to ouabain. J. Pharmacol. Exp. Ther. 140, 324–328 (1963)
Moskopf, E., Sarre, H.: Der Einfluß von Digitoxin auf die Nebenniere des Meerschweinchens im Schwimmversuch. Klin. Wochenschr. 32, 327 (1954)
Nadeau, R., de Champlain, J.: Comparative effects of 6-hydroxy-dopamine and of reserpine on ouabain toxicity in the rat. Life Sci. 13, 1753–1761 (1973)
Nadeau, R.A., James, T.N.: Antagonistic effects on the sinus node of acetylstrophanthidin and adrenergic stimulation. Circ. Res. 13, 388–391 (1963)
Nakgawa, A., Watanabe, M.: Digitaliswirkungen auf die Cortocosteron-Bildung in der Nebennierenrinde. Naunyn Schmiedebergs Arch. Pharmacol. 254, 355–363 (1966)
Oberg, B., Thorèn, P.: Studies on left ventricular receptors, signalling in non-medullated vagal afferents. Acta Physiol. Scand. 85, 145–163 (1972)
Östling, G.: Effect of large digitalis doses on the empty stomach of man. Acta Pharmacol. Toxicol. (Kbn.) 6, 165–168 (1950)
Pace, D.G., Gillis, R.A.: Neuroexcitatory effects of digoxin in the cat. J. Pharmacol. Exp. Ther. 193, 583–600 (1976)
Pace, D.G., Martin, P.M.: Interactions between digoxin and brief vagal bursts influencing atrioventricular conduction. J. Pharmacol. Exp. Ther. 2053, 657–665 (1978)
Pace, D.G., Thibodeaux, H.: Effect of digoxin on carotid sinus and sympathetic nerve activity. Fed. Proc. 32, 717 (1973)
Pinschmidt, N.W.: Relation of carotid and aortic mechanisms to digitalis emesis. Proc. Soc. Exp. Biol. Med. 61, 7–9 (1946)
Popov, N., Forster, W.: Über den Einfluß verschiedener Digitaliskörper auf die Monaminoxydaseaktivität in Ratten-, Meerschweinchen-und Katzengehirn. Acta Biol. Med. Ger. 17, 221–231 (1966)
Quest, J.A., Gillis, R.A.: Carotid sinus reflex changes produced by digitalis. J. Pharmacol. Exp. Ther. 1772, 650–661 (1971)
Quest, J.A., Thibodeaux, H., Clancy, M.M., Evans, D.E.: Neural mechanisms involved in digitalis-induced bradycardia. Fed. Proc. 32, 717 (1973)
Reiter, M., Noè, J.: Besteht ein Antagonismus zwischen Corticosteron und Strophanthin bezüglich der inotropen Wirkung am Herzmuskel? Naunyn Schmiedebergs Arch. Pharmacol. 238, 75–76 (1960)
Ricken, K.: Interaktionen von Digitalisglykosiden mit östrogenen Hormonen. Inaugural-Dissertation, Universität Düsseldorf 1975
Riggert, H., Schwab, M.: Der Einfluß von Digitoxin auf die Atmung des herzgesunden Menschen. Z. Ges. Exp. Med. 125, 80–92 (1955)
Roy, A.R., Chatterjee, M.L.: Effect of ouabain on the catecholamine content of heart and adrenal gland of rabbit. Life Sci. 9, 395–401 (1970)
Saxena, P.R., Bhargava, K.P.: The importance of a central adrenergic mechanism in the cardiovascular responses to ouabain. Eur. J. Pharmacol. 31, 332–346 (1975)
Schwab, M., Wagner, P.H.: Der Einfluß von K-Strophanthin auf die Atmung des herzgesunden Menschen. Z. Ges. Exp. Med. 129, 28–32 (1957)
Seifen, E.: Evidence for participation of catecholamines in cardiac action of ouabain: positive chronotropic effect. Br. J. Pharmacol. 514, 481–490 (1974)
Share, N.N., Chai, C.Y., Wang, S.C.: Emesis induced by intracerebroventricular injections of apomorphine and deslanoside in the dog. Fed. Proc. 23, 349 (1964)
Spann, J.F., Sonnenblick, E.H., Cooper, T., Chidsey, C.A., Willman, V.L., Braunwald, E.: Studies on digitalis XIV: Influence of cardiac norepinephrine stores on the response of isolated heart muscle to digitalis. Circ. Res. 19, 326–331 (1968)
Stickney, K.L.: Differential species sensitivity to the inhibitory effect of cardiac glycosides on 3-H-1-noradrenaline accumulation by tissue slices. Arch. Int. Pharmacodyn. Ther. 224, 215–229 (1976)
Stickney, J.L., Lucchesi, B.R.: The effect of sympatholytic agents on the cardiovascular responses produced by the injection of acetylstrophanthidin into the cerebral ventricles. Eur. J. Pharmacol. 6, 1–7 (1969)
Stickney, J.L., Meyers, F.H.: Digitalis toxicity: Development of cardiac arrhythmias in spontaneously breathing vs. artificially respired dogs. Am. Heart J. 854, 501–505 (1973)
Stoffer, S.S., Hynes, K.M., Jiang, N-S., Ryan, R.J.: Digoxin and abnormal serum hormone levels. J. Am. Med. Assoc. 225, 1643–1644 (1973)
Sulser, F., Kunz, H.A., Gantenbein, R., Wilbrandt, W.: Zur Frage einer antagonistischen Wirkung zwischen Herzglykosiden und Corticosteroiden auf die Elektrolytausscheidung der Niere. Naunyn Schmiedebergs Arch. Pharmacol. 235, 400–411 (1959)
Swamy, V.C., Hamlin, R.L., Wolf, H.H.: Influence of myocardial catecholamines on the cardiac action of ouabain. J. Pharm. Sci. 510, 1505–1507 (1965)
Takagi, M., Zanuttini, D., Khalil, E., Bellet, S.: Tolerance of reserpinized dogs to digitalis. Am. J. Cardiol. 15, 203–205 (1965)
Tanz, R.D.: The action of ouabain on cardiac muscle treated with reserpine and dichloroisoproterenol. J. Pharmacol. Exp. Ther. 144, 205–213 (1964)
Tanz, T.D., Coram, W.M., Brining, C., Cavaliere, T.: The inotropic action of ouabain in relation to ventricular norepinephirine content. Arch. Int. Pharmacodyn. Ther. 173, 294–305 (1968)
Tatra, G. von, Nissel, W.: Zur Frage der östrogenen Wirksamkeit von Herzglykosiden. Wien. Med. Wochenschr. 24, 460–463 (1969)
Toda, N., West, T.O.: The influence of ouabain on cholinergic responses in the sinoatrial node. J. Pharmacol. Exp. Ther. 1531, 104–113 (1966)
Tsao, D.P.N., King, T.E.: Communications: Effect of cardiac glycosides on 11-hyroxylation of the adrenal system. Arch. Biochem. Biophys. 118, 259–260 (1967)
Unterman, D., DeGraff, A.C., Kuppermann, H.S.: Effect of hypoadrenalism and excessive doses of desoxycorticosterone acetate upon response of the rat to ouabain. Circ. Res. 3, 280–284 (1955)
Varadi, A., Földes, J.: Serum digoxin in patients with thyroid disease. Br. Med. J. 1, 175 1976.
Vernikos-Danellis, J., Marks, B.H.: Pituitary inhibitory effects of digitoxin and hydrocortisone. Proc. Soc. Exp. Biol. Med. 109, 10–14 (1962)
Viana, A.P.: Role of adrenergic mechanisms in cardiac and respiratory effects of digoxin. Pharmacology 15, 436–444 (1977)
Wang, S.C., Borison, H.L.: A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulfate, and cardiac glycosides. Gastroenterology 221, 1–12 (1952)
Weaver, L.C., Akera, T., Brody, T.M.: Digoxin toxicity: Primary sites of drug action on the sympathetic nervous system. J. Pharmacol. Exp. Ther. 191, 1–9 (1976)
Weinberg, S.J., Haley, T.J.: Centrally mediated effects of cardiac drugs: Strophanthin-K, quinidine, and procainamide. Circ. Res. 3, 103–109 (1955)
Wolff, G.: Über das Verhalten des Blutzuckers nach Strophanthin-Injektionen. Med. Monatsschr. 8, 514–518 (1955)
Wolff, J., Maurey, J.R.: Cardiac glycosides and thyroidal iodide transport. Nature 4640, 957 (1958)
Zinnith, F.: Die Vaguswirkung auf den Blutdruck unter Rescinnamin und Strophanthin. Acta. Biol. Med. Ger. 3, 82–89 (1959)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Joubert, P.H. (1981). Effects of Cardiac Glycosides on Autonomic Nervous System and Endocrine Glands. In: Greeff, K. (eds) Cardiac Glycosides. Handbook of Experimental Pharmacology, vol 56 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68163-9_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-68163-9_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68165-3
Online ISBN: 978-3-642-68163-9
eBook Packages: Springer Book Archive